Ignite Creation Date:
2024-05-06 @ 5:53 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05463263
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2022-06-30
Brief Title:
A Phase 12 Study of STP938 for Adult Subjects With RelapsedRefractory B-Cell and T-Cell Lymphomas
Sponsor:
Step Pharma SAS
Organization:
Step Pharma SAS
Organization Data
Organization:
Step Pharma SAS
Class:
INDUSTRY
Study ID:
STP938-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Step Pharma SAS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None